Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
293.08
-5.35 (-1.79%)
Streaming Delayed Price
Updated: 11:40 AM EST, Nov 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
59
60
Next >
Better Dividend Growth Stock: AbbVie or Amgen?
February 29, 2024
A strong case can be made for owning both of these dividend growth stocks. But one of them is the better buy.
Via
The Motley Fool
Amazon Stock: Why it's Finally Included in the Dow Index
February 29, 2024
Amazon replaced Walgreens in the Dow. While a positive move for Amazon, any impact on the stock's price may be limited due to low index weighting.
Via
MarketBeat
Topics
Economy
Stocks
Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs
February 26, 2024
Amgen's growth outlook in 2024, with updates on key programs and upcoming catalysts. Goldman Sachs sees significant opportunities despite exclusivity losses. Dive into potential market moves and...
Via
Benzinga
3 Biotech Stocks to Buy and Hold for the Next 10 Years
February 26, 2024
There's a lot to like about these three drugmakers right now, and that shouldn't stop anytime soon.
Via
The Motley Fool
Amgen Options Trading: A Deep Dive into Market Sentiment
February 23, 2024
Via
Benzinga
This Is What Whales Are Betting On Amgen
February 15, 2024
Via
Benzinga
Behind the Scenes of Amgen's Latest Options Trends
February 12, 2024
Via
Benzinga
Why the dividend investor may take a look at NASDAQ:AMGN.
February 12, 2024
Exploring AMGEN INC (NASDAQ:AMGN)'s dividend characteristics.
Via
Chartmill
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
February 23, 2024
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.
Via
Investor's Business Daily
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
February 22, 2024
With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year.
Via
InvestorPlace
If You Invested $20,000 in Amgen in 2014, This Is How Much You Would Have Today
February 17, 2024
Has Amgen been a market-beating stock?
Via
The Motley Fool
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness
February 15, 2024
Although the healthcare innovation space has struggled recently, these contrarian biotech stocks now offer compelling discounts.
Via
InvestorPlace
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
February 14, 2024
Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive.
Via
InvestorPlace
Amgen Dips Despite Beating Fourth-Quarter Sales Expectations
February 06, 2024
Amgen beat sales and earnings estimates late Tuesday, helped by nine products that hit record sales.
Via
Investor's Business Daily
Earnings Scheduled For February 6, 2024
February 06, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.
Via
Benzinga
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade
February 14, 2024
Investors interested in a steadily rising stream of passive income will find what they're looking for with these dividend payers.
Via
The Motley Fool
Topics
Stocks
Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?
February 14, 2024
It faces both clinical and competitive barriers, but they might not matter.
Via
The Motley Fool
Drivers And Stock Pickers
February 13, 2024
As opposed to drivers who overestimate themselves, we seek to be above-average stock pickers by doing the things that most professional investors struggle with, like being courageous and patient.
Via
Talk Markets
Stock Market Hits Highs As AI Plays Arm, Palantir Skyrocket: Weekly Review
February 08, 2024
The S&P 500 hit 5,000. Arm, Palantir and Cloudflare rose sharply.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Are these frigid Dow stocks in for a longer winter?
February 08, 2024
These three Dow laggards have suffered double-digit percentage declines this winter, contributing to the Dow’s underperformance versus other major averages.
Via
MarketBeat
Topics
Economy
Stocks
2 Unstoppable Stocks to Buy and Hold for 2024 and Beyond
February 08, 2024
These great businesses are persisting and thriving through challenging economic times.
Via
The Motley Fool
Investors' Focus Around Amgen's Obesity Drug Data Shadows Better Than Expected Q4 Earnings
February 07, 2024
Amgen's Q4 2023: 15% net profit growth, $8.2 billion total revenues beat expectations. Prolia leads with 12% sales jump. Analysts' reactions and price targets.
Via
Benzinga
META The Next Great Dividend Growth Stock – Growth Stock – Either Or Both?
February 07, 2024
A technical analysis of Meta Platforms Inc. (aka Facebook) and its recent initiation of a dividend.
Via
Talk Markets
34% of the Dow Jones Industrial Average's Weighting Is Determined by Just 5 Stocks
February 07, 2024
Five well-known Dow Jones components account for more than a third -- over 13,100 points -- of its value.
Via
The Motley Fool
Topics
Stocks
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
February 07, 2024
Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments...
Via
Benzinga
Topics
Stocks
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
February 06, 2024
Some of the best stocks to buy in February according to MarketMaster AI suggest that a major economic recovery is underway.
Via
InvestorPlace
Topics
Artificial Intelligence
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
February 06, 2024
At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in...
Via
Benzinga
Topics
Economy
US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator
February 06, 2024
The stock rally that propelled the S&P 500 and the Dow to record highs last week seems to have stalled, with Fed officials remaining non-committal about rate-cut plans.
Via
Benzinga
Topics
Economy
Stocks
3 Fantastic Dow Stocks to Buy in February 2024
February 05, 2024
The venerable index is more representative of today's economy and these three Dow stocks to buy are brightly shining component stars.
Via
InvestorPlace
Topics
Economy
Stocks
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
February 05, 2024
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.
Via
InvestorPlace
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
59
60
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today